Anti-neural antibodies have been identified as key diagnostic biomarkers for autoimmune diseases of the central nervous system, such as the pathogenic roles of anti-NMDAR and anti-LGI1 antibodies in autoimmune encephalitis, and anti-AQP4 antibodies in NMOSD. Here, LGI1 is linked to autoimmune disease.